SCHEMBL21169581

SCHEMBL21169581

C=C/C=C\C(=C/C=C)Cc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 2/20 0.38
CES2 O00748 1/20 0.38
AKR1B1 P15121 1/20 0.38
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
HIF1A Q16665 1/20 0.33
FNTA P49354 1/20 0.32
FNTB P49356 1/20 0.32
TSHR P16473 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPK1 P28482 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CTBP2 P56545 1/20 0.32
EPHX2 P34913 1/20 0.32
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22432863 0.85 CES1 (0.38) CES1CES2AKR1B1MEN1KMT2A
SCHEMBL19119624 0.84 CES1 (0.36) CES1CES2AKR1B1MEN1KMT2A
SCHEMBL14922391 0.84 CES1 (0.36) CES1CES2AKR1B1MEN1KMT2A
SCHEMBL21791732 0.82 CES1 (0.41) CES1CES2AKR1B1MEN1KMT2A
SCHEMBL24309957 0.82 KEAP1 (0.41) HDAC8HDAC6ALDH1A1MAPK1CA1
SCHEMBL20169824 0.82 CTBP2 (0.34) MEN1KMT2AHDAC8HDAC6ALDH1A1
SCHEMBL11058375 0.77 CES1 (0.40) CES1CES2AKR1B1MEN1KMT2A
SCHEMBL21549608 0.76 CALM1 (0.43) CES1CES2AKR1B1MEN1KMT2A
SCHEMBL4933301 0.76 CES1 (0.48) CES1CES2AKR1B1MEN1KMT2A
SCHEMBL433490 0.74 CES1 (0.44) CES1CES2AKR1B1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11578166-B2 Composition for curable resin, cured product of said composition, production method for said composition and said cured product, and semiconductor device ENEOS CORPORATION (JP) 2023-02-14 US disclosed
EP-3283577-B1 REACTIVE COMPOSITIONS CONTAINING MERCAPTO-FUNCTIONAL SILICON COMPOUND MOMENTIVE PERFORMANCE MAT INC (US) 2019-07-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11578166-B2 Composition for curable resin, cured product of said composition, production method for said composition and said cured product, and semiconductor device SEM1, SMARCA1, SMARCD2 CES1 591/4885CES2 170/4885AKR1B1 2075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.